 | • レポートコード：D005-14871 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、スタチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。スタチンの種類別市場規模（アストロバスタチン、フルバスタチン、ロバスタチン、プラバスタチン、シンバスタチン、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Aurobindo Pharma、Novartis International、Pfizer、Concord Biotech、GlaxoSmithKline、Biocon、Merck ・地域別グローバル市場分析 2015年-2020年 ・スタチンの北米市場（アメリカ、カナダ、メキシコ） ・スタチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・スタチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・スタチンの南米市場（ブラジル、アルゼンチン） ・スタチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アストロバスタチン、フルバスタチン、ロバスタチン、プラバスタチン、シンバスタチン、その他 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Statins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Statins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Statins market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Statins market has been segmented into
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
By Application, Statins has been segmented into:
Hospitals
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Statins market presented in the report. This section sheds light on the sales growth of different regional and country-level Statins markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Statins market.
The report offers in-depth assessment of the growth and other aspects of the Statins market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Statins Market Share Analysis
Statins competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Statins sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Statins sales, revenue and market share for each player covered in this report.
The major players covered in Statins are:
AstraZeneca
Aurobindo Pharma
Novartis International
Pfizer
Concord Biotech
GlaxoSmithKline
Biocon
Merck
Among other players domestic and global, Statins market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Statins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Statins, with price, sales, revenue and global market share of Statins in 2018 and 2019.
Chapter 3, the Statins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Statins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Statins market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Statins sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Statins Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Statins Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Astrovastatin
1.2.3 Fluvastatin
1.2.4 Lovastatin
1.2.5 Pravastatin
1.2.6 Simvastatin
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Statins Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Overview of Global Statins Market
1.4.1 Global Statins Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aurobindo Pharma SWOT Analysis
2.2.4 Aurobindo Pharma Product and Services
2.2.5 Aurobindo Pharma Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis International
2.3.1 Novartis International Details
2.3.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis International SWOT Analysis
2.3.4 Novartis International Product and Services
2.3.5 Novartis International Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Concord Biotech
2.5.1 Concord Biotech Details
2.5.2 Concord Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Concord Biotech SWOT Analysis
2.5.4 Concord Biotech Product and Services
2.5.5 Concord Biotech Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biocon SWOT Analysis
2.7.4 Biocon Product and Services
2.7.5 Biocon Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Statins Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Statins Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Statins Manufacturer Market Share in 2019
3.3.2 Top 6 Statins Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Statins Sales, Revenue and Market Share by Regions
4.1.1 Global Statins Sales and Market Share by Regions (2015-2020)
4.1.2 Global Statins Revenue and Market Share by Regions (2015-2020)
4.2 North America Statins Sales and Growth Rate (2015-2020)
4.3 Europe Statins Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Statins Sales and Growth Rate (2015-2020)
4.5 South America Statins Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Statins Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Statins Sales, Revenue and Market Share by Country
5.1.1 North America Statins Sales and Market Share by Country (2015-2020)
5.1.2 North America Statins Revenue and Market Share by Country (2015-2020)
5.2 United States Statins Sales and Growth Rate (2015-2020)
5.3 Canada Statins Sales and Growth Rate (2015-2020)
5.4 Mexico Statins Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Statins Sales, Revenue and Market Share by Country
6.1.1 Europe Statins Sales and Market Share by Country (2015-2020)
6.1.2 Europe Statins Revenue and Market Share by Country (2015-2020)
6.2 Germany Statins Sales and Growth Rate (2015-2020)
6.3 UK Statins Sales and Growth Rate (2015-2020)
6.4 France Statins Sales and Growth Rate (2015-2020)
6.5 Russia Statins Sales and Growth Rate (2015-2020)
6.6 Italy Statins Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Statins Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Statins Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Statins Revenue and Market Share by Regions (2015-2020)
7.2 China Statins Sales and Growth Rate (2015-2020)
7.3 Japan Statins Sales and Growth Rate (2015-2020)
7.4 Korea Statins Sales and Growth Rate (2015-2020)
7.5 India Statins Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Statins Sales and Growth Rate (2015-2020)
7.7 Australia Statins Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Statins Sales, Revenue and Market Share by Country
8.1.1 South America Statins Sales and Market Share by Country (2015-2020)
8.1.2 South America Statins Revenue and Market Share by Country (2015-2020)
8.2 Brazil Statins Sales and Growth Rate (2015-2020)
8.3 Argentina Statins Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Statins Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Statins Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Statins Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Statins Sales and Growth Rate (2015-2020)
9.3 Turkey Statins Sales and Growth Rate (2015-2020)
9.4 Egypt Statins Sales and Growth Rate (2015-2020)
9.5 South Africa Statins Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Statins Sales and Market Share by Type (2015-2020)
10.2 Global Statins Revenue and Market Share by Type (2015-2020)
10.3 Global Statins Price by Type (2015-2020)
11 Global Statins Market Segment by Application
11.1 Global Statins Sales Market Share by Application (2015-2020)
11.2 Global Statins Revenue Market Share by Application (2015-2020)
11.3 Global Statins Price by Application (2015-2020)
12 Market Forecast
12.1 Global Statins Sales, Revenue and Growth Rate (2021-2025)
12.2 Statins Market Forecast by Regions (2021-2025)
12.2.1 North America Statins Market Forecast (2021-2025)
12.2.2 Europe Statins Market Forecast (2021-2025)
12.2.3 Asia-Pacific Statins Market Forecast (2021-2025)
12.2.4 South America Statins Market Forecast (2021-2025)
12.2.5 Middle East & Africa Statins Market Forecast (2021-2025)
12.3 Statins Market Forecast by Type (2021-2025)
12.3.1 Global Statins Sales Forecast by Type (2021-2025)
12.3.2 Global Statins Market Share Forecast by Type (2021-2025)
12.4 Statins Market Forecast by Application (2021-2025)
12.4.1 Global Statins Sales Forecast by Application (2021-2025)
12.4.2 Global Statins Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Statins Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Statins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Statins Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Statins Major Business
Table 9. AstraZeneca Statins Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Statins Product and Services
Table 12. AstraZeneca Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Aurobindo Pharma Statins Major Business
Table 15. Aurobindo Pharma Statins Total Revenue (USD Million) (2018-2019)
Table 16. Aurobindo Pharma SWOT Analysis
Table 17. Aurobindo Pharma Statins Product and Services
Table 18. Aurobindo Pharma Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis International Basic Information, Manufacturing Base and Competitors
Table 20. Novartis International Statins Major Business
Table 21. Novartis International Statins Total Revenue (USD Million) (2018-2019)
Table 22. Novartis International SWOT Analysis
Table 23. Novartis International Statins Product and Services
Table 24. Novartis International Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Statins Major Business
Table 27. Pfizer Statins Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Statins Product and Services
Table 30. Pfizer Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Concord Biotech Basic Information, Manufacturing Base and Competitors
Table 32. Concord Biotech Statins Major Business
Table 33. Concord Biotech Statins Total Revenue (USD Million) (2018-2019)
Table 34. Concord Biotech SWOT Analysis
Table 35. Concord Biotech Statins Product and Services
Table 36. Concord Biotech Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Statins Major Business
Table 39. GlaxoSmithKline Statins Total Revenue (USD Million) (2018-2019)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Statins Product and Services
Table 42. GlaxoSmithKline Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Biocon Basic Information, Manufacturing Base and Competitors
Table 44. Biocon Statins Major Business
Table 45. Biocon Statins Total Revenue (USD Million) (2018-2019)
Table 46. Biocon SWOT Analysis
Table 47. Biocon Statins Product and Services
Table 48. Biocon Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Statins Major Business
Table 51. Merck Statins Total Revenue (USD Million) (2018-2019)
Table 52. Merck SWOT Analysis
Table 53. Merck Statins Product and Services
Table 54. Merck Statins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Statins Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Statins Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Statins Sales by Regions (2015-2020) (K Units)
Table 58. Global Statins Sales Market Share by Regions (2015-2020)
Table 59. Global Statins Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Statins Sales by Countries (2015-2020) (K Units)
Table 61. North America Statins Sales Market Share by Countries (2015-2020)
Table 62. North America Statins Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Statins Revenue Market Share by Countries (2015-2020)
Table 64. Europe Statins Sales by Countries (2015-2020) (K Units)
Table 65. Europe Statins Sales Market Share by Countries (2015-2020)
Table 66. Europe Statins Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Statins Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Statins Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Statins Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Statins Sales by Countries (2015-2020) (K Units)
Table 71. South America Statins Sales Market Share by Countries (2015-2020)
Table 72. South America Statins Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Statins Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Statins Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Statins Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Statins Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Statins Revenue Market Share by Countries (2015-2020)
Table 78. Global Statins Sales by Type (2015-2020) (K Units)
Table 79. Global Statins Sales Share by Type (2015-2020)
Table 80. Global Statins Revenue by Type (2015-2020) (USD Million)
Table 81. Global Statins Revenue Share by Type (2015-2020)
Table 82. Global Statins Sales by Application (2015-2020) (K Units)
Table 83. Global Statins Sales Share by Application (2015-2020)
Table 84. Global Statins Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Statins Market Share Forecast by Regions (2021-2025)
Table 86. Global Statins Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Statins Market Share Forecast by Type (2021-2025)
Table 88. Global Statins Sales Forecast by Application (2021-2025)
Table 89. Global Statins Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Statins Picture
Figure 2. Global Sales Market Share of Statins by Type in 2019
Figure 3. Astrovastatin Picture
Figure 4. Fluvastatin Picture
Figure 5. Lovastatin Picture
Figure 6. Pravastatin Picture
Figure 7. Simvastatin Picture
Figure 8. Others Picture
Figure 9. Statins Sales Market Share by Application in 2018
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Global Statins Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Statins Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Statins Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Statins Sales Market Share by Manufacturer in 2019
Figure 33. Global Statins Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Statins Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Statins Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Statins Revenue Market Share by Regions (2015-2020)
Figure 40. Global Statins Revenue Market Share by Regions in 2018
Figure 41. North America Statins Sales and Growth Rate (2015-2020)
Figure 42. Europe Statins Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Statins Sales and Growth Rate (2015-2020)
Figure 44. South America Statins Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Statins Sales and Growth Rate (2015-2020)
Figure 46. North America Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Statins Sales Market Share by Countries (2015-2020)
Figure 48. North America Statins Sales Market Share by Countries in 2018
Figure 49. North America Statins Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Statins Revenue Market Share by Countries in 2018
Figure 51. United States Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Statins Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Statins Revenue Market Share by Countries in 2019
Figure 57. Germany Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Statins Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Statins Revenue Market Share by Regions 2019
Figure 65. China Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Statins Sales Market Share by Countries in 2019
Figure 72. South America Statins Revenue Market Share by Countries in 2019
Figure 73. Brazil Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Statins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Statins Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Statins Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Statins Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Statins Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Statins Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Statins Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Statins Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Statins Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Statins Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Statins Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Statins Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
酵素阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enzyme Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 152460 million by 2025, from USD 147910 million in 2019. The Enzyme Inhibitors …- コレステロール低下薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cholesterol-Lowering Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 19930 million by 2025, from USD 17940 million in 2019. The Cholesterol…
- 頸動脈狭窄薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Carotid Ttenosis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Carotid Ttenosis Drugs…
- 筋肉刺激装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Muscle Stimulator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 659.8 million by 2025, from USD 579.2 million in 2019. The Muscle Stimulator ma…
- 馬用手術台の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Equine Operating Tables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Equine Operating Tabl…